Clinical Trials Browser

Genetic Testing × Breast × Clear all

NCT06058377 2026-05-27

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Phase 3 Recruiting

Anatomic Stage II Breast Cancer AJCC v8

NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02664389 2026-05-06

PANEL

Phase NA Terminated

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03233191 2026-05-05

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Phase 3 Active not recruiting

108,508 enrolled

Breast Screening

NCT07558343 2026-04-30

MATADOR2

Phase NA Not yet recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT04475640 2026-04-02

Cancer Genetic Testing in Ethnic Populations

Phase NA Recruiting

Brain Neoplasms, Breast Neoplasms, Neoplasms, Unknown Primary

NCT04354675 2026-03-31

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT01334021 2026-03-09

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Phase 2 Active not recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT05694559 2026-02-19

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT04494945 2026-01-23

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Phase NA Recruiting

27,500 enrolled

BreastGastrointestinalGynecologic

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT02620852 2025-11-25

WISDOM

Phase NA Recruiting

100,000 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Breast Neoplasms, Depression, Hot Flashes

NCT03246841 2024-12-12

TUMOSPEC

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT04002986 2023-07-24

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

Phase NA Completed

Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8

NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Phase 1 Completed

BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT05545254 2022-09-19

Health-promoting Lifestyle in a Genetic Counseling Clinic

Breast Neoplasms

NCT04638725 2022-08-03

SIGHER

HER2-positive Breast Cancer

NCT02541188 2021-12-10

MediSein

Breast Neoplasms

NCT01460186 2019-01-15

StoRM

Phase NA Completed

Breast Neoplasms, Neoplasm Metastasis

NCT02485626 2016-10-31

HARBOR

Breast Neoplasms, Cardiovascular Diseases